Drug Development Solutions

81. Comprehensive Services For Ophthalmic Drug Development 4/9/2024

    With our specialized support, you can be confident that your ophthalmic drug will not only meet regulatory standards but also address unmet medical needs in the most expedited manner possible.

82. Container Closure Integrity Testing

    Lonza’s Drug Product Services delivers a holistic approach to DP development that prevents problems early and produces a product that is fit for purpose.

83. Surfactant Analysis Services

    Successful drug product development should integrate formulation, manufacturing process, primary packaging, device and delivery to the patient. Lonza’s Drug Product Services (DPS) offering delivers a holistic approach to DP development that anticipates and prevents problems early, and ensures the result is a product that is fit for purpose.

84. Use The Right Tools To Improve Cell Lines And Production Yields 5/15/2023

    Learn about antibody production and purification, engineering antibodies for developability, and antibody humanization while also exploring an integrated pipeline that enables the direct application of machine learning tools.

85. Formulation Strategies For Poorly Soluble Molecules 3/3/2022

    As the number of poorly soluble compounds continues to increase in the industry development pipeline, conventional formulation strategies may not be sufficient to achieve acceptable levels of solubility in the gastrointestinal tract and hence absorption into the systemic circulation.

86. Comprehensive CGT And Nucleic Acids Analytical Capabilities 9/27/2024

    By leveraging the capabilities of a CDMO, you can focus on the core aspects of your therapy development, confident in the knowledge that your manufacturing and compliance needs are being expertly managed.

87. Leveraging An Innovative Conjugation Technology For Better ADCs

    Learn how an advanced conjugation technology can provide a more uniform DAR profile, enhanced linker stability, and improved pharmacokinetic properties, paving the way for more efficacious ADCs.

88. Formulation Development: Navigate The Complex Concept-To-Market Path 7/11/2024

    By leveraging cutting-edge technological advancements, researchers can optimize formulations in terms of solubility, delivery method, safety profile, and sustained stability.

89. Better Solutions For Your Drug Product

    With world-class facilities, the state-of-the-art equipment and some of the industry’s most talented people, you can feel confident that your small molecule drug product is in safe hands. Learning from decades working with other small molecules, INCOG has been purpose-built to provide better solutions for the global injectable drug product sector.

90. Customized CMC Solutions

    Leverage customizable CMC solutions to address unique developmental challenges and propel your molecule toward IND filing and beyond, ensuring an efficient transition to the next stage of development.